Prime Medicine, Inc.PRMENASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-32.31%
↑ 80% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-164.17%
Historical baseline
PeriodValue
2025-32.31%
202425.72%
2023-25.48%
2022-286.79%
2021-514.75%
2020-315.59%
20190.00%